COVID-19 Research and SARS-CoV-2 Surveillance

COVID-19 Research and SARS-CoV-2 Surveillance

Roche Solutions for COVID-19 Research and SARS-CoV-2 Surveillance

Since its emergence in late 2019, SARS-coronavirus 2 (SARS-CoV-2) and the resulting disease, COVID-19, have spread to over 200 countries, caused over 1M human deaths, and created tremendous economic hardship around the world. Because the virus can be transmitted asymptomatically, it is especially difficult to contain viral transmission and to track its spread… especially as the virus evolves and more highly contagious variants emerge.

Roche has joined thousands of scientists around the world in the effort to understand this disease, track its spread, identify emerging variants, and accelerate the detection of both SARS-CoV-2 and the antibodies against it.

In addition to the Roche Solutions for clinical COVID-19 testing, our workflows and reagents for next-generation sequencing (NGS) and real-time PCR-based analysis offer a powerful set of tools for COVID-19 research and surveillance of SARS-CoV-2 variants. Choose from diverse solutions based on next-generation sequencing or real-time PCR.

RNA Strand

NGS Workflow

Sequence the SARS-CoV-2 viral genome from COVID-19-positive samples to better understand the virus and its transmission. Use next-generation sequencing to track existing variants (e.g.., B.1.1.7, B.1.351, P1) and identify new variants.

Learn More
LightCycler 480

Real-time PCR Workflow

The LightCycler® 480 System and LightCycler® 96 System are high-performance PCR platforms that provide methods for detection of viral genomes, gene detection, gene expression analysis, genetic variation analysis, and array data validation. During the COVID-19 pandemic, the LightCycler® 480 System is being used for critical research that has led to numerous Emergency Use Authorization submissions for SARS-CoV-2 Molecular Detection Assays.

Learn more